CC-90001: Clinical Trials

7 trials of CC-90001, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed. 7 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 17Completed 7

Follow CC-90001: new trials by email Literature Review of CC-90001 trials Research Report on CC-90001

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of BMS-986360/CC-90001 Alone and in Combination With Chemotherapy or Nivolumab in Advanced Solid Tumors
BMS-986360, Docetaxel, Nivolumab - Advanced Solid Tumors
Phase 1CompletedBristol-Myers Squibb702022-12-092025-06-13
A Study of Safety, Tolerability, and Pharmacokinetics of Multiple-Dose CC-90001 in Japanese and Caucasian Healthy Subjects
CC-90001 - Healthy Volunteer
Phase 1CompletedCelgene602019-04-042020-05-08
A Study to Assess the Pharmacokinetics of CC-90001 in Subjects With Mild, Moderate, and Severe Hepatic Impairment Compared With Healthy Subjects
CC-90001 - Hepatic Impairment
Phase 1CompletedCelgene402018-12-062020-07-27
A Study to Evaluate the Effect of Multiple Doses of CC-90001 on the Pharmacokinetics of Omeprazole, Midazolam, Warfarin, Rosuvastatin, Metformin, Digoxin, and Nintedanib in Healthy Adult Subjects
CC-90001, Omeprazole, Midazolam - Heathy Volunteer
Phase 1CompletedCelgene562017-12-042019-01-25
Safety and PK Study of CC-90001 in Subjects With Pulmonary Fibrosis
CC-90001 - Pulmonary Fibrosis
Phase 1CompletedCelgene162015-08-052017-04-04
Effect of UV Exposure on the PD of Multiple Doses of CC-90001 and Pilot Food Effect Study
CC-90001 - Healthy Subjects
Phase 1CompletedCelgene Corporation262014-11-012015-08-19
First-in-human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of CC-90001
CC-90001, Placebo - Healthy Volunteers
Phase 1CompletedCelgene Corporation962014-02-012014-10-15

Conditions studied

Pulmonary Fibrosis (1)

Sponsors

Celgene (4)  ·  Celgene Corporation (2)  ·  Bristol-Myers Squibb (1)

Countries

United States (7)  ·  Australia (2)  ·  Argentina (1)  ·  Canada (1)  ·  Chile (1)  ·  France (1)  ·  Italy (1)  ·  Mexico (1)  ·  Spain (1)

Top investigators

Daniel Weiss, MD (2)  ·  Ed O'Mara, MD (1)  ·  Francisco Ramirez-Valle, MD, PhD. (1)  ·  Kofi Mensah, MD, PhD (1)  ·  Ying Ye, PhD (1)